Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$56.27 - $73.77 $1,913 - $2,508
-34 Reduced 31.19%
75 $5,000
Q4 2023

Feb 06, 2024

SELL
$59.06 - $75.72 $34,195 - $43,841
-579 Reduced 84.16%
109 $8,000
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $2,110 - $3,169
-32 Reduced 4.44%
688 $47,000
Q2 2023

Aug 15, 2023

SELL
$62.68 - $95.05 $17,738 - $26,899
-283 Reduced 28.22%
720 $68,000
Q1 2023

Apr 27, 2023

SELL
$47.19 - $70.77 $16,280 - $24,415
-345 Reduced 25.59%
1,003 $68,000
Q4 2022

Feb 07, 2023

BUY
$30.35 - $53.15 $5,038 - $8,822
166 Added 14.04%
1,348 $67,000
Q3 2022

Oct 28, 2022

BUY
$31.97 - $49.37 $127 - $197
4 Added 0.34%
1,182 $38,000
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $712 - $1,524
20 Added 1.73%
1,178 $46,000
Q1 2022

May 04, 2022

BUY
$57.56 - $82.54 $690 - $990
12 Added 1.05%
1,158 $81,000
Q4 2021

Feb 07, 2022

BUY
$72.5 - $100.68 $45,820 - $63,629
632 Added 122.96%
1,146 $89,000
Q3 2021

Nov 02, 2021

BUY
$90.24 - $124.05 $4,241 - $5,830
47 Added 10.06%
514 $49,000
Q2 2021

Aug 11, 2021

BUY
$93.66 - $139.27 $10,115 - $15,041
108 Added 30.08%
467 $58,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $6,294 - $8,370
54 Added 17.7%
359 $47,000
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $30,381 - $43,346
305 New
305 $40,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.